News

IMPAKT 2015: Gene expression signatures may signal clinical activity of palbociclib in patients with breast cancer

8 May 2015
IMPAKT 2015: Gene expression signatures may signal clinical activity of palbociclib in patients with breast cancer

Two recently identified and tested gene-expression signatures may guide clinicians in selecting which patients may show a response to palbocicib, according to findings presented at the IMPAKT Breast Cancer Conference held 7–9 May 2015 in Brussels, Belgium.

Click here to read the article in full.

Source: ESMO